TNFSF10 and head and neck squamous cell carcinoma: While bortezomib treatment alone showed only a slight effect on the activation of apoptotic pathways, bortezomib markedly enhanced TRAIL-induced apoptosis in HNSCC cells, accompanied by increased processing of caspase-3, -8 and -9.